WO2026133296 - PEPTIDE INHIBITORS OF FIBRINOLYSIS, METHODS, AND USES THEREOF
National phase entry is expected:
Publication Number
WO/2026/133296
Publication Date
25.06.2026
International Application No.
PCT/IB2025/063277
International Filing Date
19.12.2025
Title **
[English]
PEPTIDE INHIBITORS OF FIBRINOLYSIS, METHODS, AND USES THEREOF
[French]
INHIBITEURS PEPTIDIQUES DE LA FIBRINOLYSE, MÉTHODES ET UTILISATIONS ASSOCIÉES
Applicants **
HEMAB APS
Inventors
GANDHI, Prafull S.
HÄGER, Mattias
ØSTERGAARD, Henrik
BAK-THOMSEN, Theresa Helene
DEEMAND, Amalie Carnbring
SØRENSEN, Benny
REA, Catherine
HJØRRINGGAARD, Claudia
TRAN, Poanna
NYGAARD, Mads Mørup
Priority Data
63/737,322
20.12.2024
US
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
EPO
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| 译文 |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 4464 | |
| EPO | Filing, Examination, Granting | 71701 | |
| Japan | Filing, Examination, Granting | 4374 | |
| South Korea | Filing, Examination, Granting | 6957 | |
| USA | Filing, Examination, Granting | 22740 |
Total:
110,236
Contact Us
Abstract[English]
Provided herein are synthetic peptide inhibitors of fibrinolysis, pharmaceutical compositions comprising at least one of the presently disclosed peptides, or a pharmaceutically acceptable salt thereof, and uses thereof.[French]
La présente invention concerne des inhibiteurs peptidiques synthétiques de la fibrinolyse, des compositions pharmaceutiques comprenant au moins l'un des peptides présentement divulgués, ou un sel pharmaceutiquement acceptable de ceux-ci, ainsi que leurs utilisations.